Technical Information Research Resources for Cancer Preventive Agent Development
Note: There have been new actions to this contract opportunity. To view the most recent action, please click here.
Looking for contract opportunity help?
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
General Information
- Contract Opportunity Type: Sources Sought (Updated)
- Updated Published Date: Nov 02, 2022 03:57 pm EDT
- Original Published Date: May 02, 2022 09:06 am EDT
- Updated Response Date: Jun 01, 2022 04:00 pm EDT
- Original Response Date: Jun 01, 2022 04:00 pm EDT
- Inactive Policy: 15 days after response date
- Updated Inactive Date:
- Original Inactive Date:
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code:
- NAICS Code:
- 541690 - Other Scientific and Technical Consulting Services
- Place of Performance: Rockville , MD 20850USA
Description
The National Institutes of Health (NIH) National Cancer Institute (NCI), Division of Cancer Prevention (DCP) has over 40 active clinical trials, 15 trials in development and is the sponsor for approximately 35 INDs (Investigational New Drug Applications). The mission of DCP is to plan and direct cancer prevention research, including testing promising agents in human clinical trials as part of a drug development program. Such testing falls under the purview of regulatory agencies such as the FDA and requires certain documentation for the use of the investigational agent. The collection, preparation, submission and continual update of this documentation is the focus of this acquisition.
The purpose of this acquisition is to provide a variety of information management functions necessary to support the identification, development, and qualification of potential cancer preventive agents for investigational new drug (IND) applications to the Food and Drug Administration (FDA) for clinical trials.
The proposed acquisition will involve the following type of activities, further defined in the attached draft Statement of Work (SOW Attachment 1):
1) Task Area 1: Cancer Preventive Agent Identification, Documentation, and Prioritization
2) Task Area 2: Cancer Preventive Agent Data and Report Analysis, Status and Documentation (PRECLINICAL)
3) Task Area 3: Cancer Preventive Agent Data and Report Analysis, Status and Documentation (CLINICAL)
4) Task Area 4: Information Management System
5) General Tasks in support of DCP related to the SOW requirements
Attachments/Links
Contact Information
Contracting Office Address
- OFFICE OF ACQUISITIONS 31Center Dr. 11A35P
- Bethesda , MD 20892
- USA
Primary Point of Contact
- Brittany M. Gibau
- brittany.gibau@nih.gov
- Phone Number 2402766863
Secondary Point of Contact
History
- Nov 12, 2022 11:56 pm ESTSources Sought (Updated)
- Nov 02, 2022 03:57 pm EDTSources Sought (Updated)
- Jun 16, 2022 11:55 pm EDTSources Sought (Original)